Orthopedic Surgery Doctors in Walterboro, SC Accepting Medicare

4 Orthopedic Surgery doctors found. Showing 1 - 4

Jeffrey Holman, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 120 Medical Park Dr, Walterboro, SC 29488 Phone: 843-782-4141    Fax: 843-549-7967

Dr. James Paul Marro, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Medical Park Dr, Walterboro, SC 29488 Phone: 843-782-4141    Fax: 843-549-7967

David Rosen, PA-C Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Medical Park Dr, Walterboro, SC 29488 Phone: 843-782-4141    Fax: 843-549-7967

Lawrence L. Conley Ii, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Medical Park Dr, Walterboro, SC 29488 Phone: 843-782-4141    Fax: 843-549-7967

News Archive

State of the Union address includes brief, but clear, defense of health law

President Barack Obama made clear that he is willing to tinker around the edges of the sweeping reform, but not return to the days before the measure became law. Media outlets analyzed the specifics of his comments and offered a big picture view of the impact of the entire speech, including fact-checking some of his related policy ideas and budget recommendations.

Ranbaxy introduces Atorvastatin-Amlodipine besylate tablets in the U.S.

Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., has launched an authorized generic version of Caduet in the U.S. market, as part of an agreement with Pfizer Inc.

Study reveals role of 'Kurly' protein found in cilia

A new study of a protein found in cilia - the hair-like projections on the cell surface - may help explain how genetic defects in cilia play a role in developmental abnormalities, kidney disease and a number of other disorders.

Study finds PARP1 and EZH2 as potential therapeutic targets for small cell lung cancer

Newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the results of a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

Read more Medical News

› Verified 3 days ago